|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00131586 |
|
Date of registration:
|
17/08/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
|
|
Scientific title:
|
Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins |
|
Date of first enrolment:
|
April 2003 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00131586 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Michael Sawyer, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Alberta Health Services |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- To have lung or colorectal cancer and be treated with either oxaliplatin, carboplatin
or cisplatin
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Colorectal Cancer
|
|
Lung Cancer
|
|
Secondary ID(s)
|
|
SP-11-0033/ethics 17173
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|